Cardiff Oncology, Inc. (CRDF) Earnings
|
Expand Research on CRDF
| Next EPS Date | 7/29/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +2.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -13.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/30/26  |
Q126 | N/A | -$0.18 | N/A | N/A | $72.86K | N/A | N/A | N/A | ||
| 2/26/26 |
Q425 | N/A | -$0.19 | N/A | N/A | $105.56K | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | -$0.17 | -$0.21 | +$0.04 | $120K | $125K | N/A |  | | Details | |
| 11/3/25 |
Q325 | N/A | -$0.21 | N/A | N/A | $125K | N/A | N/A | N/A | ||
| 10/30/25 |
Q325 | N/A | -$0.21 | N/A | N/A | $125K | N/A | N/A | N/A | ||
| 7/29/25 |
Q225 | -$0.21 | -$0.19 | -$0.02 | $120K | $96.43K | N/A | | | Details | |
| 5/8/25 |
Q125 | -$0.20 | -$0.19 | -$0.01 | $100K | $91.67K | N/A | | | Details | |
| 5/6/25 |
Q125 | N/A | -$0.19 | N/A | N/A | $91.67K | N/A | N/A | N/A |
